Up until now Alzheimer’s can only be detected through cognitive tests.
Krtin Nithiyanandam from the UK has developed an antibody which attaches to the neurotoxic proteins that are typically to be present in the very first stages of the disease. Through the fluorescent particles connect to the antibody the brain scan can trace the disease.
We congratulate Krtin and are excited see to how this will further develop.
Source / Read more: The Telegraph